THE BIZNOB – Global Business & Financial News – A Business Journal – Focus On Business Leaders, Technology – Enterpeneurship – Finance – Economy – Politics & Lifestyle
Seattle Genetics and Immunomedics signed a development and licensing agreement on Friday that required Seattle Genetics to pay Immunomedics $250 million up front for...
Notice:
The Biznob uses cookies to provide necessary website functionality, improve your experience and analyze our traffic. By using our website, you agree to
our Privacy Policy and our Cookie Policy.